K-252a

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameK-252a
Drug Alias NameTrkA inhibitor (Bio3/Creabilis)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNerve growth factor receptor Trk-A antagonistsNerve growth factor receptors antagonists
TargetsNerve growth factor receptor Trk-ANerve growth factor receptors
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBio3 Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBio3 ResearchCreabilis Sa
Active IndicationsN/A
Inactive IndicationsPsoriasis

Other Information

ATC CodeN/A
Related LinksN/A